Allogeneic Valve Transplantation

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Boston Children's Hospital
Study ID
NCT06387446
Status
Recruiting
Apply to this trial

Conditions

  • Valve Disease, Aortic
  • Valve Disease, Heart
  • Valve Heart Disease

Eligibility Criteria

Sex
ALL
Age
30 Days - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Valve transplant — PROCEDURE
    Heart valves from an organ donor will be transplanted into recipient

Study Details

Valves will be taken from hearts donated by organ donors, and implanted into patients who need a new heart valve.

Key Dates

First listed
Apr 29, 2024
Start date
May 1, 2024
Status verified
Sep 2024
Primary completion
Jun 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
4 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Valve transplantation group
    This arm undergoes Allogeneic Valve transplantation

Primary Outcome Measure

Valve Regurgitation [ Time Frame: One year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02115
Sitaram Emani, MD

Find similar trials in Boston, MA

By research site
Boston Children's Hospital· Boston, MA

Related Studies